Logotype for So-Young International Inc

So-Young International (SY) Q1 2025 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for So-Young International Inc

Q1 2025 earnings summary

17 Mar, 2026

Executive summary

  • Q1 2025 revenues were RMB 297.3 million (US$41.0 million), with a net loss of RMB 33.1 million (US$4.6 million), mainly due to increased investment in expanding branded aesthetic centers.

  • The company is executing a vertical integration strategy, expanding its branded SoYoung Clinic network in major Chinese cities, focusing on high-quality, standardized, non-surgical treatments.

  • 23 clinics operated in nine cities by quarter-end; 18 achieved positive monthly operating cash flow, and 16 were profitable in March.

  • Customer satisfaction remains high at 4.98/5, with strong growth in paid visits and treatments year-over-year.

  • Branded aesthetic centers achieved triple-digit year-over-year revenue growth, reflecting strong operational momentum.

Financial highlights

  • Total revenues down 60.6% year-over-year, mainly due to fewer medical service providers subscribing to platform services.

  • Aesthetic treatment services revenue surged 551.4% year-over-year to RMB 98.8 million, driven by branded center expansion.

  • Cost of revenues rose 29.1% year-over-year to RMB 151.4 million, mainly from branded center expansion; cost of aesthetic treatment services up 547.6%.

  • Operating expenses fell 20.4% year-over-year to RMB 189.3 million; sales and marketing, G&A, and R&D expenses all declined.

  • Gross profit for Q1 2025 was RMB 145.9 million, down from RMB 201.0 million in Q1 2024.

  • Net loss widened to RMB 33.1 million from RMB 21.2 million a year ago; non-GAAP net loss was RMB 31.5 million versus a profit last year.

  • Cash and equivalents totaled RMB 1.1 billion as of March 31, 2025, down from RMB 1.25 billion at year-end 2024.

Outlook and guidance

  • Q2 2025 aesthetic treatment services revenue expected between RMB 120–140 million, up 337.3%–410.1% year-over-year.

  • Continued investment in branded clinic network and vertical integration, prioritizing long-term value over short-term gains.

  • Guidance reflects current market and operating conditions and is subject to change.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more